» Articles » PMID: 30944681

Fibromatosis - Immunohistochemical Evaluation, Differential Diagnosis from Gastrointestinal Tumors, and Other Mesenchymal Tumours

Overview
Publisher Termedia
Specialty Gastroenterology
Date 2019 Apr 5
PMID 30944681
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Fibromatosis is a histologically benign growth of fibroblastic and myofibroblastic cells, with a potential to recur and invade local organs. It can occur as a superficial or deep form. Visceral fibromatosis and superficial fibromatosis are histologically similar. They both have alterations in the WNT signalling pathway, but mutations in the APC or β-catenin gene do not occur in superficial fibromatoses.

Aim: To present four cases of deep fibromatosis and one case of Peyronie's disease, along with immunohistochemical staining analysis and the criteria for differential diagnosis.

Material And Methods: All patients were hospitalised in the Central Clinical Hospital of the MSWiA in Warsaw during the period of 2012-2015. Surgical specimens were examined, and tissue samples were embedded in paraffin blocks.

Results: As the result of the study we present a short algorithm of immunostainings that can be useful in differential diagnosis. When a spindle cell tumour is encountered in the abdomen a gastrointestinal stromal tumor (GIST) should always be excluded; therefore, a CD117 staining is recommended as the first step. When the staining is negative, fibromatosis can be taken into consideration. β-Catenin staining should be done in order to confirm that diagnosis.

Conclusions: The diagnosis of fibromatosis is not always simple; GISTs can easily be mistaken for it. Immunohistochemical staining with CD34 and CD117 antibodies are useful in differential diagnosis. DTF should present negative stainings for S100, CD34, CD99, and bcl-2, which can help to distinguish it from other mesenchymal tumours.

Citing Articles

Challenges in Diagnosing Adolescent Goiter: A Case Report with Brief Literature Insights in Juvenile Desmoid-Type Fibromatosis of the Thyroid Gland.

Brad G, Juganaru I, Nicoara D, Scutca A, Bugi M, Asproniu R J Clin Med. 2025; 14(2.

PMID: 39860616 PMC: 11766264. DOI: 10.3390/jcm14020610.


A Rare Case of Inflammatory Myofibroblastic Tumor Mimicking Fibrous Adhesions Resulting in Bowel Obstruction.

Washburn S, Thomas R, Grider D Case Rep Surg. 2024; 2024:7782678.

PMID: 39544284 PMC: 11561171. DOI: 10.1155/2024/7782678.


Annotating the Role of F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies-Is It Really an Advantageous Tool?.

Kumar S, Singh H, Kaman L, Nada R, Mittal B Nucl Med Mol Imaging. 2024; 58(3):140-146.

PMID: 38633285 PMC: 11018563. DOI: 10.1007/s13139-024-00846-5.


Non-IgG4-Related Fibrosing Mediastinitis Diagnosed on Core Needle Biopsy and Treated with Steroids: A Case Study and Review of the Differential Diagnoses.

Malkova K, Wilhelm A, Uddin H, Okereke I, Muthukumarana V Int J Surg Pathol. 2024; 32(6):1215-1221.

PMID: 38234079 PMC: 11337727. DOI: 10.1177/10668969231219646.


Retroperitoneal spindle cell tumor: a case report.

Kim I, Ahn E, Yoon J, Choi A, Joo S J Surg Case Rep. 2023; 2023(10):rjad601.

PMID: 37942340 PMC: 10629943. DOI: 10.1093/jscr/rjad601.


References
1.
Montgomery E, Lee J, Abraham S, Wu T . Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol. 2001; 14(7):695-701. DOI: 10.1038/modpathol.3880374. View

2.
Seow-Choen F . The management of desmoids in patients with familial adenomatous polyposis (FAP). Acta Chir Iugosl. 2008; 55(3):83-7. DOI: 10.2298/aci0803083s. View

3.
Robanus-Maandag E, Bosch C, Amini-Nik S, Knijnenburg J, Szuhai K, Cervera P . Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids. PLoS One. 2011; 6(9):e24354. PMC: 3170296. DOI: 10.1371/journal.pone.0024354. View

4.
Mignemi N, Itani D, Fasig J, Keedy V, Hande K, Whited B . Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors. Cancer Sci. 2012; 103(12):2173-80. PMC: 4278584. DOI: 10.1111/cas.12037. View

5.
Hughes D, Kummar S, Lazar A . New, tolerable γ-secretase inhibitor takes desmoid down a notch. Clin Cancer Res. 2014; 21(1):7-9. PMC: 4306586. DOI: 10.1158/1078-0432.CCR-14-1660. View